UK markets open in 6 hours 17 minutes
  • NIKKEI 225

    29,443.30
    -724.97 (-2.40%)
     
  • HANG SENG

    29,412.13
    -662.04 (-2.20%)
     
  • CRUDE OIL

    62.83
    -0.70 (-1.10%)
     
  • GOLD FUTURES

    1,767.40
    -8.00 (-0.45%)
     
  • DOW

    31,402.01
    -559.85 (-1.75%)
     
  • BTC-GBP

    33,545.95
    -2,694.07 (-7.43%)
     
  • CMC Crypto 200

    935.59
    -59.07 (-5.94%)
     
  • ^IXIC

    13,119.43
    -478.54 (-3.52%)
     
  • ^FTAS

    3,788.74
    -6.32 (-0.17%)
     

COVID-19 Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast - ResearchAndMarkets.com

·4-min read

The "The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast" report has been added to ResearchAndMarkets.com's offering.

This new report quantifies the impact that COVID-19 has had on the global MD&D market and forecasts how the publisher expects the market to rebound, by segment and by competitor.

The year 2020 has been both devastating and energizing for the global MD&D industry as a whole. The COVID-19 pandemic, whose impact first shut down and then curtailed routine medical, hospital and surgical care around the world, delayed normal market growth which, even now, is threatened by a possible second, mutation-induced pandemic. Hardest hit have been companies that serve surgical markets and those dominated by office- and clinic-based services, e.g., aesthetics, hearing, dental.

On the other hand, developers of IVD tests that diagnose the SARS-CoV-2 virus and manufacturers of infection control disposables, critical care and respiratory products have seen their revenues skyrocket to the point that some have been unable to keep up with demand. The result has been a roller coaster but mostly disappointing year for the industry, although MD&D companies can take comfort in the knowledge that they have not faced these hardships by themselves and, as an industry, have actually responded to the pandemic with great competence, ingenuity and care for their employees, patients, clinicians and stockholders.

Earlier in the year, the publisher released reports providing insights into: 1) the anticipated impact of the COVID-19 pandemic on the global MD&D market by major technology; and 2) MD&D companies' apparent exposure to the pandemic based on the composition of their product portfolios. The current report provides a wrap up of the year's positives and negatives. It forecasts 2020 revenues for 50 of the largest MD&D companies by franchise as well as forecasts for nearly 100 technologies grouped into 23 segments for 2020 and 2021. The publisher did not venture beyond 2021 except to comment in the text on how far full recovery for a technology market might stretch into that year.

Companies Mentioned

  • 3M

  • Abbott Laboratories

  • AbbVie/Allergan plc

  • Alcon

  • Align Technology

  • Arthrex

  • Asahi Kasei

  • B. Braun Melsungen

  • Baxter International

  • Becton Dickinson

  • bioMerieux

  • Boston Scientific

  • Canon Medical Systems

  • Cardinal Health

  • Coloplast

  • ConvaTec

  • Cooper Companies

  • Danaher Corporation

  • Demant

  • Dentsply Sirona

  • Edwards Lifesciences

  • Elekta

  • Envista

  • Fresenius SE & Co. KGaA

  • FujiFilm

  • GE Healthcare

  • Getinge

  • Hillrom

  • Hologic

  • Intuitive Surgical

  • Johnson & Johnson

  • Medtronic

  • Molnlycke

  • Nipro

  • Olympus Corporation

  • Philips Healthcare

  • ResMed

  • Roche Diagnostics

  • Siemens Healthineers

  • Smith & Nephew

  • Sonova

  • Steris

  • Straumann

  • Stryker

  • Sysmex

  • Teleflex

  • Terumo

  • Thermo Fisher Scientific

  • Varian Medical Systems

  • Zimmer-Biomet

Key Topics Covered:

1.0 INTRODUCTION

2.0 COVID-19 IMPACT ON MD&D MARKETS BY TECHNOLOGY

2.1 In Vitro Diagnostics (IVD)

2.2 Diagnostic Imaging

2.3 Cardiovascular Technologies

2.3.1 Cardiac Rhythm Management (CRM)

2.3.2 Transcatheter Technologies

2.3.3 Cardiac Surgery

2.4 Orthopedic Technologies

2.4.1 Reconstruction

2.4.2 Trauma Products

2.4.3 Spine Products

2.4.4 Other Products

2.4.5 Major Orthopedic Trends

2.5 Dental Technologies

2.6 Endoscopy

2.7 Renal & Urology Technologies

2.8 Drug Delivery

2.9 Energy-Based Technologies

2.9.1 Radiation Therapy

2.9.2 Lasers

2.9.3 Low Frequency Electromagnetic

2.9.4 Radiofrequency

2.9.5 Ultrasound

2.9.6 Cryo

2.9.7 Other Energy

2.10 Wound Care

2.11 Critical Care

2.12 Infection Control

2.13 Hearing Technologies

2.15 Contact Lenses

2.16 Ophthalmic Surgery

2.17 Patient Beds, Wheelchairs, Transport and Aids

2.18 Aesthetic Technologies

2.19 Blood Donation & Management

2.20 Home Respiratory Technologies

2.21 Surgical Robotics

2.22 Neurostimulation

2.23 Surgical Tables, Lights & Fixed

2.24 Hernia Mesh

3.0 COVID-19 IMPACT ON GLOBAL MD&D COMPANIES

3.1 Overall Response of Global MD&D Industry to COVID-19 Pandemic

3.1.1 Company Challenges

3.1.2 Company Opportunities

3.2 MD&D Company Revenue Trends and Opportunities

For more information about this report visit https://www.researchandmarkets.com/r/c7dt2e

View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005249/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900